Large Cap Biopharma: January ’17 Update

By Rod Raynovich of Raygent
Tuesday, January 31, 2017 9:24 PM EDT

Large Cap Biopharmaceuticals: Jan. 2016 Compared to Jan.2017

  • Stock prices are compared for the one year bear market 1/7/16-1/31/17.
  • Financial metrics will be updated after all earnings are reported.
  • Dividends have gone up with stock prices down: ABBV, BMY, AMGN, GILD.
  • Only one stock is up YoY: Celgene (CELG) up 2%.
  • XBI is up 5% YoY; IBB is down 8.6%.

 

Disclosure: Long ABBV, ARRY, FBIOX, GILD, MRK, RHHBY.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Chee Hin Teh • 7 years ago • Member's comment

Thanks for sharing

Chee Hin Teh • 7 years ago • Member's comment

Thanks sir for sharing